NEWS SEARCH ANALYSIS INSIGHT

360° SearchNetwork Hot Spots Trends

Advanced Search Options >>

Saturday, November 21, 2009 7:02 PM

Boston Scientific Corporation

Type: Company

Name: Boston Scientific Corporation

Nationality: United States

Fact Sheet: Fact Sheet for Boston Scientific Corporation

First Reported 11/20/2009 - Updated 12 hours ago - 7 Documents

Food and Drug Administration

Boston Scientific gets FDA clearance, CE Mark for WallFlex Fully Covered Esophageal Stent

- US medical devices maker Boston Scientific Corporation (NYSE: BSX) said today it has received 510(k) clearance from the US Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex Fully Covered Esophageal Stent for the treatment ... [Pharmacy Choice - 12 hours ago]

Entities: Stent, esophageal, CE Mark, Boston Scientific Corporation, Food and Drug Administration

First Reported 21 hours ago - Updated 5 hours ago - 2 Documents

King Juan Carlos

Boston Scientific to leave Doral

Medical products company , which has more than 1,200 employees working out of a 14-acre plant in Doral, is relocating its operation to Costa Rica over the next three years.Doral Mayor Juan Carlos Bermudez said he received a call from the Beacon Council ... [Philadelphia Business Journal - 5 hours ago]

Entities: Boston Scientific Corporation, King Juan Carlos, Costa Rica

First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Internet & IT)

Clorox Company

Wall Street News Alert: Market Watch: BOCL - November 9, 2009

Wall Street News Alert's 'stocks to watch' this morning are: Bio-Clean, Inc. (OTCBB: BOCL), Ford Motor Company (NYSE: F), The Clorox Company (NYSE: CLX) and Boston Scientific Corporation (NYSE: BSX).Yesterday, Bio-Clean, Inc. (OTCBB: BOCL) issued a press ... [PR-USA.net - 11/19/2009]

Entities: Wall Street, Clorox Company, Boston Scientific Corporation, New York Stock Exchange

First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents

Former Boston Scientific venture captures $30m series B

This site is owned and operated by Informa plc ('Informa') whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36 ... [Clinica - 11/20/2009]

Entities: Boston Scientific Corporation, Informa PLC, Wales, England

First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents

Medtronic Inc

US Senate Bill Includes Lower $2 Billion Medical Device Tax

WASHINGTON -(Dow Jones)- The key health-care overhaul issue now facing medical-device companies is when they may have to start paying a collective $2 billion-per-year tax proposed in Congress.The amount itself now seems set and has been halved from an ... [CNN Money - 11/19/2009]

Entities: Taxes, US Senate, Medtronic Inc

First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents

2009 Tech Citizenship honoree: Boston Scientific Corp.

Natick-based medical device company Boston Scientific Corp. has for years given back to the community through the Boston Scientific Foundation, which supports local and national programs that improve lives in the areas of health and education for the ... [Mass High Tech - 11/19/2009]

Entities: Boston Scientific Corporation, Sohar Power Company, England, Paul Donovan

First Reported 11/16/2009 - Updated 11/16/2009 - 1 Documents (in Politics)

Becton Dickinson and Company

Top 25 Healthcare Supply Chains

AMR Research ranks healthcare companies on innovation By Nov. 16, 2009 » Last week AMR Research released its Healthcare Top 25, which ranks companies that have best demonstrated leadership in building supply chain excellence and innovation that ... [Industry Week - 11/16/2009]

Entities: Health Care, Becton Dickinson and Company, Supply Chain, Invention

First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents (in Internet & IT)

Notable Analyst Rating Changes 11/17: XOM, PALM, ALKS, ITW, SINA Upgraded; SPWRA, PARD, PSUN, JOYG Downgraded

UPGRADES:Barclays upgrades Exxon Mobil Corp. (NYSE: XOM) from Equal Weight to Overweight and raised their price target from $90 to $92.Kaufman Bros. upgrades Palm, Inc. (NASDAQ: PALM) from Hold to Buy with a $16 price target. http://www.streetinsider ... [Street Insider - 11/17/2009]

Entities: SINA Corporation, Palm Inc, SandRidge Energy Inc, HTML, Morgan Joseph

First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents

Morgan Joseph Initiates Coverage on Boston Scientific (BSX) with a Hold; Shares Fully Valued

Morgan Joseph initiates coverage on Boston Scientific (NYSE: BSX) with a Hold.Morgan analyst says, "The stock has traded between 9x-15x over the past two years at a discount to the comp group range of 13x-16x and currently trades at 16x 2009 consensus ... [Street Insider - 11/17/2009]

Entities: Boston Scientific Corporation, Morgan Joseph, Stent, Taxus, Induction

First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents

BRIEF-RESEARCH ALERT-UBS raises Boston Scientific, Zimmer to buy

Nov 18 (Reuters) - :* UBS raises Boston Scientific Zimmer Holdings to buy fromneutral* UBS raises Abbott Laboratories price target to $61 from $57* UBS raises Baxter International Inc price target to $64 from $62* UBS raises Boston Scientific Corp price ... [Forbes.com - 11/18/2009]

Entities: UBS AG, Boston Scientific Corporation, Zimmer Holdings Incorporated, Stryker Corporation, Edwards Life Sciences Corp

First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents (in Internet & IT)

UBS Upgrades Boston Scientific (BSX) to Buy

UBS upgrades Boston Scientific (NYSE: BSX) from Neutral to Buy. Price target increased to $10.To see all the upgrades/downgrades on shares of BSX, visit our Analyst Ratings page.Boston Scientific Corporation operates as a developer, manufacturer, and ... [Street Insider - 11/18/2009]

Entities: Boston Scientific Corporation, UBS AG, Medical Devices

First Reported 11/06/2009 - Updated 11/07/2009 - 11 Documents

Boston Scientific reaches agreement with DOJ related to product advisories issued by its Guidant subsidiary

Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales ... [News-Medical.Net - 11/07/2009]

Entities: Guidant Corporation, Boston Scientific Corporation, Ray Elliott, Food and Drug Administration

Quotes

...that many jobs, it's significant,'' said Nero, whose organization manages business recruitment and retention on behalf of the county government. "It's never a good thing when we're trying to promote a cluster in life sciences and you lose a company like Boston Scientific. It's just not good."

Boston Scientific to close Doral plant, eliminate 1,400 jobs [Miami Herald - 21 hours ago]

...Covered Esophageal Stents represents a tremendous milestone for Boston Scientific," said Michael Phalen, President, Boston Scientific Endoscopy. "This advanced line of esophageal stents is designed to improve the quality of life for the thousands of patients suffering from esophageal cancer. We are pleased that our entire WallFlex Stent family -- biliary, enteral and now esophageal -- is available in the U S , Europe and other strategic international markets. This underscores our mission to meet the high expectations of our customers and deliver a complete range of innovative treatment options to diagnose, palliate and treat patients with diseases of the gastrointestinal tract."

Boston Scientific's WallFlex Fully Covered Esophageal Stent receives FDA clearance and CE Mark ap ... [News-Medical.Net - 11/20/2009]

Morgan analyst says, "The stock has traded between 9x-15x over the past two years at a discount to the comp group range of 13x-16x and currently trades at 16x 2009 consensus EPS. We view the shares as being fully valued. Risks associated with the stock include the timing and success of clinical trials, new product launch timing, availability of reimbursement, litigation, and healthcare reform...Boston Scientific is a turnaround story, in our view, led by a new management team that is trying to increase gross margins with a combination of manufacturing rationalization, new products, and intensified marketing efforts. BSC is a big ship to turn, however...The drug eluting stent (DES) product mix is currently shifting from TAXUS to the newer PROMUS stent, which is supplied to BSC by Abbott Labs (NYSE: ABT). The good news is that having two stent platforms is helping the company preserve its market-leading position in drug eluting stents. The bad news is that the gross margin on a PROMUS stent is half that of the TAXUS, which is likely to pressure margins in the Cardiovascular business until the next-generation PROMUS Element is introduced."

Morgan Joseph Initiates Coverage on Boston Scientific (BSX) with a Hold; Shares Fully Valued [Street Insider - 11/17/2009]

More Content

sort by: Date \| Relevance
Boston Scientific to leave Doral [Philadelphia Business Journal - 5 hours ago]
Boston Scientific gets FDA clearance, CE Mark f... [Pharmacy Choice - 12 hours ago]
WallFlex Esophageal Stent Gets FDA OK, CE Mark [EndoNurse - 19 hours ago]
Company Gets 510(k), CE Marking for Esophageal ... [FDA News - 19 hours ago]
Boston Scientific to close Doral plant, elimina... [Miami Herald - 21 hours ago]
US EQUITIES WEEK AHEAD: H-P Results, Home Sales... [CNN Money - 23 hours ago]
24 Tech Citizens honored today for generosity [Mass High Tech - 11/20/2009]
TriVascular2 Raises $30 Million [Private Equity HUB - 11/20/2009]
Former Boston Scientific venture captures $30m ... [Clinica - 11/20/2009]
UBS upbeat on medical tech stocks [Financial News USA - 11/20/2009]
FDA Clearance and CE Mark for Boston Scientific... [ASM International - 11/20/2009]
Boston Scientific's WallFlex Fully Covered Esop... [News-Medical.Net - 11/20/2009]
Market Report -- In Play (BSX) [Briefing.com via MSN Money - 11/20/2009]
BRIEF-Boston Scientific announces FDA clearance... [Forbes.com - 11/20/2009]
Boston Scientific Announces FDA Clearance and C... [Earthtimes.org - 11/20/2009]
Boston Scientific (BSX) Receives 510(k) Clearan... [Street Insider - 11/20/2009]
Boston Scientific Announces FDA Clearance and C... [PR Newswire via MSN Money - 11/20/2009]
AHA: Obesity and Smoking Major Risk Factors for... [MedPage Today - 11/20/2009]
US Senate Bill Includes Lower $2 Billion Medica... [CNN Money - 11/19/2009]
The Dimock Center helps Boston's residents — an... [Mass High Tech - 11/19/2009]
2009 Tech Citizenship honoree: Boston Scientifi... [Mass High Tech - 11/19/2009]
Industry, government, academia make work force ... [Mass High Tech - 11/19/2009]
Wall Street News Alert: Market Watch: BOCL - No... [PR-USA.net - 11/19/2009]
Day Two in DC: Can pharma police everything onl... [Medical Marketing And Media - 11/19/2009]
The Cardiac Device Market Outlook for 2010 [Diagnostic & Invasive Cardiology - 11/19/2009]
Optiant Updates PowerChain 6.2 With Features Th... [Street Insider - 11/18/2009]
UBS Upgrades Boston Scientific (BSX) to Buy [Street Insider - 11/18/2009]
BRIEF-RESEARCH ALERT-UBS raises Boston Scientif... [Forbes.com - 11/18/2009]
AHA: New Trumps Old in Comparison of Heart Pumps [MedPage Today - 11/18/2009]
The Future of Stent Technology Highlighted at T... [Diagnostic & Invasive Cardiology - 11/17/2009]

Blogs

sort by: Date \| Relevance
BUY OR SELL-Is Medtronic immune to device secto... [Economy-Finance - 11/18/2009] * Investors see quarterly results meeting expectations * Views diverge over long-range growth prospects By Susan Kelly CHICAGO, Nov 18 (Reuters) - In a ...
Boston Scientific Sets $296 Million Settlement ... [WSJ.com: Health Blog - 11/06/2009] Now you see it. Now you dont. So it goes with Boston Scientifics third-quarter profit as a result of a settlement agreement with the Justice Department that the ...
Alana B. Elias Kornfeld: TED MED 2009: The Futu... [The Huffington Post Full Blog Feed - 10/28/2009] Day 2 at TED MED 2009 and the energy is high. This morning's session began with John Abele, the co-founder of the Boston Scientific Corporation, who spoke ...
The Least Helpful Call You Will See Today [Jeff Matthews Is Not Making This Up - 10/21/2009] The least helpful call you will see today—and there are a number of contestants for that honor, not the least being Leerink Swann’s reduction in price target for ...
Boston Scientific Company Q3 2009 Earnings Call... [Biotech Sector and Stocks Analysis from Seeking ... - 10/21/2009] Boston Scientific Company (BSX) Q3 2009 Earnings Call October 20, 2009 8:00 am ETComplete Story » ...

Change Password

Log in to Silobreaker

Advanced Search Options

Boston Scientific Corporation